JP2017507895A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017507895A5 JP2017507895A5 JP2016520312A JP2016520312A JP2017507895A5 JP 2017507895 A5 JP2017507895 A5 JP 2017507895A5 JP 2016520312 A JP2016520312 A JP 2016520312A JP 2016520312 A JP2016520312 A JP 2016520312A JP 2017507895 A5 JP2017507895 A5 JP 2017507895A5
- Authority
- JP
- Japan
- Prior art keywords
- phase
- microparticles
- organic solvent
- risperidone
- release
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000012071 phase Substances 0.000 claims 22
- 239000011859 microparticle Substances 0.000 claims 15
- 238000000034 method Methods 0.000 claims 13
- 239000003960 organic solvent Substances 0.000 claims 11
- 229920000642 polymer Polymers 0.000 claims 10
- 238000001035 drying Methods 0.000 claims 9
- RAPZEAPATHNIPO-UHFFFAOYSA-N risperidone Chemical compound FC1=CC=C2C(C3CCN(CC3)CCC=3C(=O)N4CCCCC4=NC=3C)=NOC2=C1 RAPZEAPATHNIPO-UHFFFAOYSA-N 0.000 claims 9
- 229960001534 risperidone Drugs 0.000 claims 9
- 229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 claims 7
- 239000004372 Polyvinyl alcohol Substances 0.000 claims 6
- 229920002451 polyvinyl alcohol Polymers 0.000 claims 6
- 238000005406 washing Methods 0.000 claims 6
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 claims 4
- 239000008346 aqueous phase Substances 0.000 claims 4
- 239000000839 emulsion Substances 0.000 claims 4
- 238000010791 quenching Methods 0.000 claims 4
- 239000007864 aqueous solution Substances 0.000 claims 3
- 229940079593 drug Drugs 0.000 claims 3
- 239000003814 drug Substances 0.000 claims 3
- 230000001804 emulsifying effect Effects 0.000 claims 3
- 238000010907 mechanical stirring Methods 0.000 claims 3
- 238000002360 preparation method Methods 0.000 claims 3
- 239000000243 solution Substances 0.000 claims 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims 2
- 239000011780 sodium chloride Substances 0.000 claims 2
- JJTUDXZGHPGLLC-IMJSIDKUSA-N 4511-42-6 Chemical compound C[C@@H]1OC(=O)[C@H](C)OC1=O JJTUDXZGHPGLLC-IMJSIDKUSA-N 0.000 claims 1
- 238000004090 dissolution Methods 0.000 claims 1
- 239000002904 solvent Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP2013001821 | 2013-06-20 | ||
| EPPCT/EP2013/001821 | 2013-06-20 | ||
| PCT/EP2014/001652 WO2014202214A1 (en) | 2013-06-20 | 2014-06-18 | Preparation of polylactide-polyglycolide microparticles having a sigmoidal release profile |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017507895A JP2017507895A (ja) | 2017-03-23 |
| JP2017507895A5 true JP2017507895A5 (https=) | 2017-07-20 |
| JP6464154B2 JP6464154B2 (ja) | 2019-02-06 |
Family
ID=51022802
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016520312A Active JP6464154B2 (ja) | 2013-06-20 | 2014-06-18 | Ｓ字型放出プロファイルを有するポリラクチド−ポリグリコリド微小粒子の調製 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US9943484B2 (https=) |
| JP (1) | JP6464154B2 (https=) |
| CN (1) | CN105308101B (https=) |
| AU (1) | AU2014283692B2 (https=) |
| CA (1) | CA2916301C (https=) |
| DK (1) | DK3010962T4 (https=) |
| ES (1) | ES2640486T5 (https=) |
| FI (1) | FI3010962T4 (https=) |
| HU (1) | HUE036141T2 (https=) |
| LT (1) | LT3010962T (https=) |
| PT (1) | PT3010962T (https=) |
| RU (1) | RU2658004C2 (https=) |
| SA (1) | SA515370296B1 (https=) |
| WO (1) | WO2014202214A1 (https=) |
| ZA (1) | ZA201509354B (https=) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2956538C (en) | 2014-07-30 | 2023-01-03 | Merck Patent Gmbh | Directly compressible composition comprising microcrystalline cellulose |
| JP2016102093A (ja) * | 2014-11-28 | 2016-06-02 | ニプロ株式会社 | 塩基性の求核化合物を含有するマイクロカプセルの製造方法 |
| CA2998504C (en) | 2015-09-21 | 2023-06-20 | Teva Pharmaceuticals International Gmbh | Sustained release olanzapine formulations |
| WO2018172850A1 (en) | 2017-03-20 | 2018-09-27 | Teva Pharmaceuticals International Gmbh | Sustained release olanzapine formulaitons |
| KR102047983B1 (ko) | 2017-11-30 | 2019-11-22 | 주식회사 지투지바이오 | 안전성 및 저장 안정성이 향상된 생분해성 미립구의 제조방법 |
| GR1009870B (el) * | 2019-07-09 | 2020-11-12 | Φαρματεν Α.Β.Ε.Ε. | Φαρμακευτικο σκευασμα που περιλαμβανει ενα ατυπο αντιψυχωσικο φαρμακο και μεθοδος παρασκευης αυτου |
| KR102908216B1 (ko) * | 2019-12-31 | 2026-01-06 | 광저우 디치 파마슈티컬스 컴퍼니 리미티드 | 3차 아민 약학 조성물 및 이의 산업화 배치 제조 방법 |
| EP4125823A1 (en) | 2020-03-30 | 2023-02-08 | Biological E Limited | Risperidone microspheres, process for their prepartion and uses thereof |
| KR102259589B1 (ko) * | 2020-11-30 | 2021-06-02 | (주)인벤티지랩 | 미소구체 제조 시스템 및 미소구체 제조 방법 |
| US20240100012A1 (en) | 2021-01-18 | 2024-03-28 | Mark Hasleton | Pharmaceutical dosage form |
| US11992559B2 (en) * | 2021-02-24 | 2024-05-28 | Oakwood Laboratories, Llc | Microsphere formulations comprising lurasidone and methods for making and using the same |
| CA3227324A1 (en) | 2021-07-06 | 2023-01-12 | Mark Hasleton | Treatment of serotonin reuptake inhibitor withdrawal syndrome |
| GR1010327B (el) * | 2021-10-06 | 2022-10-17 | Φαρματεν Α.Β.Ε.Ε., | Παρατεταμενης αποδεσμευσης ενεσιμο φαρμακευτικο σκευασμα λεβοθυροξινης και μεθοδος παρασκευης αυτου |
| WO2025135778A1 (ko) * | 2023-12-18 | 2025-06-26 | 주식회사 포스테라헬스사이언스 | 약물의 특성에 따른 활성형 미립자의 제조 방법, 이의 제조 방법으로 제조된 활성형 미립자 및 상기 활성형 미립자를 이용한 약물을 포함하는 장기 지속 제형의 제조 방법 |
| WO2025207396A1 (en) * | 2024-03-27 | 2025-10-02 | Avidence Therapeutics, Inc. | Microsphere-based injectable rofecoxib formulation |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5478564A (en) * | 1990-02-22 | 1995-12-26 | Teva Pharmaceutical Industries, Ltd. | Preparation of microparticles for controlled release of water-soluble substances |
| US5288496A (en) * | 1990-05-15 | 1994-02-22 | Stolle Research & Development Corporation | Growth promoters for animals |
| WO1997026869A1 (en) * | 1996-01-24 | 1997-07-31 | United States Government Represented By The Secretary Of The Army | Novel 'burst-free' sustained release poly-(lactide/glycolide) microspheres |
| US5792477A (en) * | 1996-05-07 | 1998-08-11 | Alkermes Controlled Therapeutics, Inc. Ii | Preparation of extended shelf-life biodegradable, biocompatible microparticles containing a biologically active agent |
| US6194006B1 (en) * | 1998-12-30 | 2001-02-27 | Alkermes Controlled Therapeutics Inc. Ii | Preparation of microparticles having a selected release profile |
| US6264987B1 (en) | 2000-05-19 | 2001-07-24 | Alkermes Controlled Therapeutics Inc. Ii | Method for preparing microparticles having a selected polymer molecular weight |
| US7690026B2 (en) * | 2005-08-22 | 2010-03-30 | Microsoft Corporation | Distributed single sign-on service |
-
2014
- 2014-06-18 RU RU2016101418A patent/RU2658004C2/ru active
- 2014-06-18 HU HUE14733524A patent/HUE036141T2/hu unknown
- 2014-06-18 ES ES14733524T patent/ES2640486T5/es active Active
- 2014-06-18 FI FIEP14733524.4T patent/FI3010962T4/fi active
- 2014-06-18 CA CA2916301A patent/CA2916301C/en active Active
- 2014-06-18 PT PT147335244T patent/PT3010962T/pt unknown
- 2014-06-18 JP JP2016520312A patent/JP6464154B2/ja active Active
- 2014-06-18 LT LTEP14733524.4T patent/LT3010962T/lt unknown
- 2014-06-18 WO PCT/EP2014/001652 patent/WO2014202214A1/en not_active Ceased
- 2014-06-18 CN CN201480034979.2A patent/CN105308101B/zh active Active
- 2014-06-18 AU AU2014283692A patent/AU2014283692B2/en active Active
- 2014-06-18 DK DK14733524.4T patent/DK3010962T4/da active
- 2014-06-18 US US14/898,415 patent/US9943484B2/en active Active
-
2015
- 2015-12-17 SA SA515370296A patent/SA515370296B1/ar unknown
- 2015-12-23 ZA ZA2015/09354A patent/ZA201509354B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017507895A5 (https=) | ||
| FI3010962T4 (fi) | Sigmoidaalisen vapautumisprofiilin omaavien polylaktidi-polyglykolidimikrohiukkasten valmistus | |
| Kravanja et al. | Supercritical fluid technologies for the incorporation of synthetic and natural active compounds into materials for drug formulation and delivery | |
| JP2016509842A5 (https=) | ||
| MX362709B (es) | Microesferas de buprenorfina de fuerte carga de medicamento y su método de fabricación. | |
| AR099756A1 (es) | Nanopartículas terapéuticas que comprenden un agente terapéutico, y métodos para su elaboración y uso, composición farmacéutica | |
| JP2011126894A5 (https=) | ||
| Sagiri et al. | Encapsulation of vegetable organogels for controlled delivery applications | |
| WO2017005087A1 (zh) | 一种叶黄素饲料添加剂的制备方法 | |
| CN104689771B (zh) | 一种氧化白藜芦醇微胶囊的制备方法及其产品 | |
| Gun et al. | Formation and characterization of pH-responsive liquid core microcapsules | |
| ES2625873T3 (es) | Método de preparación de micropartículas biodegradables que contienen fármacos | |
| CN104474985B (zh) | 一种交联两性蔗渣木聚糖微球的制备方法 | |
| RU2012116085A (ru) | Наночастицы оксалиплатина и способ их получения | |
| JP2015521585A5 (https=) | ||
| CN105131313B (zh) | 一种羟丙基甲基纤维素纳米微球的制备方法 | |
| CN107353418B (zh) | 一种plga复合微球材料的制备方法 | |
| CN104910446B (zh) | 一种温度控制制备的具有温度分级释放性能的天然高分子母子微球及其制备方法 | |
| CN103721266A (zh) | 含阿维菌素类药物/氢化蓖麻油的原位胶凝注射剂 | |
| CN105749293A (zh) | 一种含氧吨酮改性高分子药物及其制备方法以及作为制备抗菌药物上的应用 | |
| RU2016118775A (ru) | Фармацевтическая композиция с контролируемым высвобождением, основанная на прионовой кислоте | |
| CN104208711B (zh) | 壳聚糖半流体缓释凝胶及用途 | |
| HRP20171402T4 (hr) | Priprava polilaktidno-poliglikolidnih mikročestica sa sigmoidnim profilom oslobađanja | |
| CN110582279A (zh) | 2-(6-甲基-吡啶-2-基)-3-基-[6-酰胺基-喹啉-4-基]-5,6-二氢-4H-吡咯并[1,2-b]吡唑的共晶，其制备方法和药物组合物 | |
| CN103242545B (zh) | 一种壳聚糖基中空球的制备方法 |